Loading insider details...
Beta
Latest Form 4 (Jun 4, 2026): Grant/Award of 1,764 LPCN shares, $3.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Lipocine Inc. (LPCN) | Grant/Award | 1,764 | $3.9K |
| Jun 5, 2025 | Lipocine Inc. (LPCN) | Grant/Award | 1,764 | $5.6K |
| Jun 7, 2024 | Lipocine Inc. (LPCN) | Grant/Award | 1,764 | $12.4K |
| May 12, 2023 | Lipocine Inc. (LPCN) | Grant/Award | 30,000 | $8.0K |
| Mar 20, 2023 | Lipocine Inc. (LPCN) | Purchase | 4,000 | $1.4K |
| Jun 10, 2022 | Lipocine Inc. (LPCN) | Grant/Award | 22,000 | $20.2K |
| Jun 10, 2021 | Lipocine Inc. (LPCN) | Grant/Award | 22,000 | $27.7K |
| Dec 28, 2020 | Inhibitor Therapeutics, Inc. (INTI) | Grant/Award | 754,839 | n/a |
| Dec 17, 2020 | Lipocine Inc. (LPCN) | Exercise/Conversion | 5,250 | n/a |
| Jun 10, 2020 | Lipocine Inc. (LPCN) | Grant/Award | 22,000 | $21.2K |